Best SellerPre-Order
BPC-157 10mg
99.2% HPLC Purity4.9 (41)
Research-grade BPC-157 (Body Protection Compound) 10mg lyophilised powder. 99.2% HPLC purity, COA verified. Stable pentadecapeptide for tissue healing and gut research.
$89.99AUD
Best SellerPre-Order
Retatrutide 10mg
SKU: PW-001 • Batch: PW-260301
99.4% HPLC PurityCOA Verified ✓
4.9 (47 reviews)
$129.99AUD
Available — Pre-Order (7–10 days)
✓Free shipping on orders over $250 AUD
✓Australia Post tracked — Standard $12.99 / Express $18.99
✓Dispatched next business day (orders before 11PM AEST)
Key Research Features
- Triple receptor agonist: GLP-1, GIP, and glucagon
- 99.4% HPLC purity — independently verified
- Full COA with mass spectrometry confirmation
- LAL endotoxin tested (<1.0 EU/mg)
- GMP-certified sourcing
- Lyophilised for maximum stability
Molecular Details
- Sequence
- LY3437943 — proprietary triple receptor agonist sequence (see COA for full data)
- Molecular Formula
- C₂₄₉H₃₉₆N₆₈O₇₂
- CAS Number
- 2381089-83-2
- Molecular Weight
- ~5766 Da
- Purity
- 99.4%
- Form
- Lyophilised powder
- Appearance
- White/off-white lyophilised powder
Purity independently verified at a leading Australian university via HPLC & mass spectrometry.
Usage & Storage
- Quantity
- 10mg / vial
- Dosage Notes
- Research protocols explore GLP-1/GIP/Glucagon receptor agonist activity at varying concentrations. Consult published clinical literature for specific study designs.
- Reconstitution
- Reconstitute with 1–2mL bacteriostatic water. Swirl gently; do not shake. Allow to fully dissolve before use.
- Injection Route
- Subcutaneous (research protocols)
- Storage Temp
- −20°C for long-term storage
- Storage Conditions
- Store lyophilised at −20°C, protected from light. After reconstitution, refrigerate at 2–8°C and use within 4 weeks.
- Packaging
- Sterile, tamper-evident research vial
Description
Retatrutide (LY3437943) is a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Supplied as a lyophilised powder at 99.4% HPLC purity with full Certificate of Analysis (COA) documentation.
Our Retatrutide is sourced exclusively from GMP-certified manufacturing facilities with full chain-of-custody documentation maintained from synthesis to our Melbourne Labs. Every batch undergoes independent third-party HPLC testing, mass spectrometry identity confirmation, LAL endotoxin assay (<1.0 EU/mg), and sterility screening before dispatch.
Research has explored Retatrutide's simultaneous activation of three complementary receptor pathways for effects on energy homeostasis, body composition, and metabolic function — producing distinct profiles compared to single (GLP-1) or dual (GLP-1/GIP) agonists studied in the literature.
Research & Guides
Frequently Asked Questions — Retatrutide
Retatrutide (LY3437943) is a triple GLP-1/GIP/Glucagon receptor agonist investigated in preclinical and clinical research for its effects on metabolic function, body weight regulation, and energy homeostasis. All use is strictly for in-vitro laboratory research only.
Our Retatrutide 10mg is independently verified at 99.4% HPLC purity. Each batch is tested by an accredited third-party laboratory and comes with a full Certificate of Analysis (COA).
Lyophilised Retatrutide should be stored at −20°C for long-term stability. Once reconstituted with bacteriostatic water, store at 2–8°C and use within 4 weeks. Avoid repeated freeze-thaw cycles.
Add bacteriostatic water (BAC water) slowly to the vial at a 1–2mL volume. Gently swirl — do not shake. Allow the lyophilised powder to dissolve completely before use in research protocols.
Yes. Retatrutide is legal to purchase in Australia for legitimate in-vitro laboratory and research purposes. It is not a scheduled substance when sold for research use. It is not approved for human consumption or therapeutic use.
Current batch: PW-260301. The COA for this batch is available on our COA Library page, including full HPLC chromatogram, purity %, mass spectrometry data, and endotoxin results.
Yes. Every batch of Retatrutide ships with a downloadable COA including HPLC purity percentage, mass spectrometry identity confirmation, sterility results, and LAL endotoxin assay data.
Semaglutide is a single GLP-1 receptor agonist, while Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. In research settings, Retatrutide's multi-receptor activity produces distinct metabolic effects compared to single-target compounds.
Yes. Peptide Labs ships Retatrutide nationwide across Australia via Australia Post with tracking. Orders placed before 11PM AEST are dispatched the next business day.
Due to high demand, Retatrutide is currently available on pre-order with dispatch within 7–10 days of payment. Use code PREORDER at checkout for 10% off your first order.
Bacteriostatic water (BAC water) is the recommended reconstitution solvent for Retatrutide. We stock pharmaceutical-grade BAC water 10mL in our Supplies category.
Frequently Bought Together
Pre-Order
GHK-Cu 50mg
99.3% HPLC Purity4.9 (53)
Research-grade GHK-Cu 50mg lyophilised powder — 99.3% HPLC purity, COA verified. Copper peptide complex for wound healing and skin research.
$94.99AUD
Pre-Order
Melanotan II 10mg
99.1% HPLC Purity4.8 (36)
Research-grade Melanotan II 10mg lyophilised powder. 99.1% HPLC purity, COA verified. Cyclic alpha-MSH analogue for pigmentation and tanning research.
$69.99AUD
Research Use Only — Important Disclaimer
Retatrutide 10mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable Australian laws and regulations. Peptide Labs Australia ABN 55 947 727 521.